Indinavir

BreastfeedingPediatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Abiraterone, Alfuzosin, Almotriptan, Alosetron, Alprazolam, Amiodarone, Amprenavir, Antacids, Antiarrhythmics, Antifungal agents, Artemether/Lumefantrine, Astemizole, Atazanavir, Atorvastatin, Atovaquone, Atovaquone/Proguanil, Avanafil, Bepridil, Bortezomib, Bosentan, Brigatinib, Brinzolamide, Cabazitaxel, Cabozantinib, Calcifediol, Calcium channel blockers, Carbamazepine, Chlordiazepoxide, Ciclesonide, Cisapride, Clarithromycin, Clonazepam, Clorazepate, Colchicine, Conivaptan, Copanlisib, Corticosteroids, Crizotinib, Cyclosporine, CYP3A4 inducers and substrates, Darifenacin, Darunavir, Dasatinib, Deferasirox, Delavirdine, Diazepam, Didanosine, Dienogest, Digoxin, Dihydroergotamine, Dronedarone, Dutasteride, Efavirenz, Enfuvirtide, Eplerenone, Ergot derivatives, Ergotamine, Estazolam, Estrogens, Etravirine, Everolimus, Felodipine, Fentanyl, Fesoterodine, Flibanserin, Flurazepam, Fluticasone Propionate, Food, Fusidic Acid, Grapefruit Juice, Guanfacine, H2-antagonists, Halazepam, Halofantrine, HMG-CoA reductase inhibitors, Itraconazole, Ixabepilone, Ketoconazole, Lapatinib, Lidocaine, Lomitapide, Lopinavir, Lovastatin, Maraviroc, Meperidine, Methylergonovine, Methylprednisolone, Methysergide, Midazolam, Midostaurin, Mifepristone, Mometasone, Nefazodone, Nelfinavir, Neratinib, Nevirapine, Nicardipine, Nifedipine, Nilotinib, Nisoldipine, Olaparib, P-glycoprotein inhibitors and inducers, Paclitaxel, Palbociclib, Pantoprazole, Paricalcitol, Pazopanib, PEG-Interferon, Phenobarbital, Phenytoin, Pimavanserin, Pimecrolimus, Pimozide, Ponatinib, Prasugrel, Protease inhibitors, Proton pump inhibitors, Quazepam, Quinidine, Quinine, Ranolazine, Ribociclib, Rifabutin, Rifampin, Rifapentine, Rilpivirine, Rivaroxaban, Romidepsin, Rosuvastatin, Ruxolitinib, Salmeterol, Saxagliptin, Sildenafil, Silodosin, Simeprevir, Simvastatin, Sirolimus, Solifenacin, Sorafenib, St John's Wort, Sunitinib, Tacrolimus, Tadalafil, Tamsulosin, Telithromycin, Temsirolimus, Tenofovir Disoproxil, Theophylline, Ticagrelor, Tolvaptan, Trazodone, Triazolam, Tricyclic antidepressants, Valproic Acid, Vardenafil, Vemurafenib, Venetoclax, Venlafaxine, Vorapaxar, Zidovudine

PREGNANCY CATEGORY: C

Protease inhibitors cause dyslipidemia which includes elevated triglycerides and cholesterol and redistribution of body fat centrally to produce the so-called 'protease paunch', breast enlargement, facial atrophy, and 'buffalo hump'.

Our database has 69 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
NAILS
MUCOSAL
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
GENITOURINARY
HEMATOLOGIC
NEUROMUSCULAR/SKELETAL
OCULAR
RENAL
RESPIRATORY
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top